Streamline Antibody Screening in Plasma
Fractionators may require that plasma provided for fractionation be within a specified acceptable maximum titre of ABO blood group antibodies and special requirements may be set relative to the absence of irregular antibodies. Plasma used for polyvalent IVIG production should also be
anti-D negative.
DG Gel System
DG Gel instruments and reagents use a proprietary card technology to help labs streamline typing and tailor an extended phenotype profile for each testing need. The instruments use a simultaneous perforation and dispensing technique that allows full use of the card wells while avoiding cross-contamination.
For enhanced flexibility, DG Gel reagents are compatible with all DG Gel instruments and include comprehensive DG Gel card profiles, reagent red blood cell options, and complete liquid antisera.
For enhanced flexibility, DG Gel reagents are compatible with all DG Gel instruments and include comprehensive DG Gel card profiles, reagent red blood cell options, and complete liquid antisera.
Erytra Automated System
The Erytra Automated System is a fully automated, high-throughput floor-based analyzer designed to perform pretransfusion compatibility tests and irregular antibody screening using DG Gel card technology.
Erytra Eflexis Automated System
The Erytra Eflexis Automated System is a fully automated desktop analyzer that uses DG Gel technology for pretransfusion compatibility tests. This system can be used for the screening of irregular antibodies in plasma for fractionation. It is the next step for scalable blood typing solutions in the Grifols portfolio.
Learn more about Grifols Workflow ConsultancyWebinars & meetings on demand. Request your virtual meeting with plasma screening experts. |
Learn More About Plasma Solutions
This information is intended for physicians and healthcare professionals only.
Product registration and availability vary by country. For more information on product availability, please contact us here.